The estimated Net Worth of Richard L Anderson is at least $808 Tysiąc dollars as of 1 October 2007. Richard Anderson owns over 83,333 units of Mannkind Corp stock worth over $807,768 and over the last 20 years Richard sold MNKD stock worth over $0.
Sign up
Richard Anderson MNKD stock SEC Form 4 insiders trading
Richard has made over 3 trades of the Mannkind Corp stock since 2004, according to the Form 4 filled with the SEC. Most recently Richard exercised 83,333 units of MNKD stock worth $662,497 on 1 October 2007.
The largest trade Richard's ever made was exercising 83,333 units of Mannkind Corp stock on 1 October 2007 worth over $662,497. On average, Richard trades about 6,794 units every 83 days since 2004. As of 1 October 2007 Richard still owns at least 131,773 units of Mannkind Corp stock.
You can see the complete history of Richard Anderson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Richard Anderson's mailing address?
Richard's mailing address filed with the SEC is 28903 NORTH AVENUE PAINE, , VALENCIA, CA, 91355.
Insiders trading at Mannkind Corp
Over the last 20 years, insiders at Mannkind Corp have traded over $14,187,027 worth of Mannkind Corp stock and bought 107,212,962 units worth $2,707,661,837 . The most active insiders traders include Alfred E Mann, Juergen Martens oraz David Thomson. On average, Mannkind Corp executives and independent directors trade stock every 27 days with the average trade being worth of $3,220,647. The most recent stock trade was executed by Stuart A Tross on 3 September 2024, trading 25,000 units of MNKD stock currently worth $156,500.
What does Mannkind Corp do?
mannkind corporation (nasdaq: mnkd) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. in addition, mannkind is applying our novel technologies and services to support partner development efforts.
What does Mannkind Corp's logo look like?
Complete history of Richard Anderson stock trades at Mannkind Corp
Mannkind Corp executives and stock owners
Mannkind Corp executives and other stock owners filed with the SEC include:
-
Michael Castagna,
Chief Executive Officer, Director -
Dr. Michael E. Castagna Pharm.D.,
CEO & Director -
Stuart Tross,
Chief People and Workplace Officer -
David Thomson,
Executive Vice President, General Counsel, Secretary -
Dr. Michael E. Castagna,
CEO & Director -
Steven Binder,
Chief Financial Officer -
Dr. David B. Thomson,
Exec. VP, Gen. Counsel & Sec. -
Joseph Kocinsky,
Chief Technology Officer -
Steven B. Binder,
Chief Financial Officer -
Joseph Kocinsky M.B.A., M.S.,
Chief Technology Officer -
Dr. Stuart A. Tross,
Chief People & Workplace Officer -
Rosabel Alinaya,
Vice President of Investor Relations, Interim Corporate Controller, Treasurer -
Christine Mundkur,
Independent Director -
Kent Kresa,
Independent Chairman of the Board -
Ronald Consiglio,
Independent Director -
Michael Friedman,
Independent Director -
James Shannon,
Independent Director -
Kevin Kaiserman,
Vice President - Medical Affairs and Safety -
Jennifer Grancio,
Independent Director -
Anthony Hooper,
Independent Director -
Alejandro Galindo M.B.A., M.S.,
Chief Commercial Officer -
James Patrick McCauley Jr., J.D., M.B.A.,
Chief Commercial Officer -
John F. Bedard,
Sr. VP of Worldwide Regulatory Affairs -
Rosabel Realica Alinaya,
VP of Investor Relations & Treasury -
Thomas Hofmann M.D., Ph.D.,
Chief Scientific Officer -
Matthew J Pfeffer,
Corporate VP and CFO -
Henry L Nordhoff,
Director -
David Mac Callum,
Director -
Raymond W. Urbanski,
Corp VP, CMO -
David M Kendall,
Chief Medical Officer -
Elizabeth Garrett Ingram,
Chief Marketing Officer -
Courtney Barton,
Chief Compl & Privacy Officer -
Patrick Mc Cauley,
Chief Commercial Officer -
John R. Riesenberger,
VP & Chief Commercial Officer -
Richard L Anderson,
VP & CFO -
Heather Hay Murren,
Director -
Kathleen Connell,
Director -
Llew Keltner,
Director -
Dan Burns,
VP & President, MKBP -
W Wendell Cheatham,
VP, Medical & Reg Affairs -
Juergen Martens,
Corporate VP -
Hakan Edstrom,
President & COO -
Alfred E Mann,
Chairman & CEO -
Diane Palumbo,
Vice President, Human Resource -
Abraham E Cohen,
Director -
Peter C Richardson,
Chief Scientific Officer -
Lauren M Sabella,
EVP Chief Operating Officer -
Alejandro Galindo,
EVP Endocrine Business Unit -
Burkhard Blank,
EVP Chief Medical Officer -
Sanjay R Singh,
EVP Technical Operations -
Christopher B Prentiss,
Chief Financial Officer -
Sabrina Kay,